Skip to content

Genetic Test for Pathogenic Variants in the *GPC3* Gene (Probe-Based)

Published: August 9, 2026Updated: August 16, 2026

This test checks for specific changes (mutations) in the GPC3 gene, which may be linked to certain inherited conditions affecting organs like the liver, kidneys, or heart.

Quick summary

["It helps identify if you carry a genetic risk for rare inherited disorders that could impact your health over time."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
106594-5
Short code
Gp B Strep DNA Fld Ql NAA+n-prb
Synonyms
Gp B Strep DNA Fld Ql NAA+n-prb
Category
coagulation
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
non-probe-amp-tar
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have a family history of conditions like *Glypican-3-associated tumors* (e.g., hepatocellular carcinoma) or other genetic syndromes linked to GPC3 variants. It’s also used in genetic counseling or pre-symptomatic screening for certain inherited disorders.

What to Expect Before the Test

No special preparation is needed. You’ll provide a blood sample (whole blood) for DNA extraction. The test analyzes your genetic material to detect specific mutations in the GPC3 gene.

What the Results Mean

Results will indicate whether you have the detected mutations. A positive result means you carry those variants, which may increase your risk for specific conditions. A negative result means no detectable mutations were found in this test. Consult your healthcare provider for personalized interpretation.

Common Conditions This Test Helps Diagnose

While GPC3 mutations are rare, they can be associated with conditions like *hepatocellular carcinoma* (liver cancer), *fibrolamellar carcinoma* (a rare liver tumor), or other hereditary syndromes. Early detection may guide monitoring or preventive strategies.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

GPC3 Gene Mutation Screening

Frequently asked questions

How often does this test cause false positives or negatives?
Like all genetic tests, there’s a small chance of false results due to technical limitations or overlapping mutations. However, this test is designed to detect specific variants linked to known conditions, reducing ambiguity. Your provider will discuss limitations with you.
Can I get this test if I don’t have a family history of related diseases?
Yes, some individuals undergo this test for general genetic screening, especially if they have symptoms or risk factors for associated conditions. It’s also used in research or carrier screening contexts.
Will my results affect my insurance or ability to get health coverage?
Genetic test results may impact insurance coverage or employment in some cases, depending on local laws. Always review your policy or consult a healthcare provider to understand potential implications.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy